PROBE-PD
  • Sobre
  • Projeto
  • Equipe
  • Publicações
  • Parkinson
  • Contato
  • Português
    • Português
  • Home
Escolha uma Página

Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer’s disease.

por jcdadm.website | jun 4, 2022 | Publication

Nilsson J, Ashton NJ, Benedet AL, Montoliu-Gaya L, Gobom J, Pascoal TA, Chamoun M, Portelius E, Jeromin A, Mendes M, Zetterberg H, Rosa-Neto P, Brinkmalm A, Blennow K. Alzheimers Res Ther. 2022 Jun 4;14(1):78. doi: 10.1186/s13195-022-01021-8.

18F-MK-6240 tau-PET in genetic frontotemporal dementia.

por jcdadm.website | jun 3, 2022 | Publication

Levy JP, Bezgin G, Savard M, Pascoal TA, Finger E, Laforce R, Sonnen JA, Soucy JP, Gauthier S, Rosa-Neto P, Ducharme S. Brain. 2022 Jun 3;145(5):1763-1772. doi: 10.1093/brain/awab392.

Mitochondrial complex I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer’s disease.

por jcdadm.website | maio 1, 2022 | Publication

Terada T, Therriault J, Kang MS, Savard M, Pascoal TA, Lussier F, Tissot C, Wang YT, Benedet A, Poltronetti NM, Ottoy J, Arias JF, Bezgin G, Matsudaira T, Bunai T, Obi T, Tsukada H, Ouchi Y, Rosa-Neto P. Eur J Neurol. 2022 May;29(5):1324-1334. doi: 10.1111/ene.15246....

Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer’s disease therapeutic.

por jcdadm.website | maio 1, 2022 | Publication

Kang MS, Shin M, Ottoy J, Aliaga AA, Mathotaarachchi S, Quispialaya K, Pascoal TA, Collins DL, Chakravarty MM, Mathieu A, Sandelius Å, Blennow K, Zetterberg H, Massarweh G, Soucy JP, Cuello AC, Gauthier S, Waterston M, Yoganathan N, Lessard E, Haqqani A, Rennie K,...

Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer’s disease.

por jcdadm.website | abr 1, 2022 | Publication

Cassidy CM, Therriault J, Pascoal TA, Cheung V, Savard M, Tuominen L, Chamoun M, McCall A, Celebi S, Lussier F, Massarweh G, Soucy JP, Weinshenker D, Tardif C, Ismail Z, Gauthier S, Rosa-Neto P. Neuropsychopharmacology. 2022 Apr;47(5):1128-1136. doi:...
Página 3 de 17«12345...10...»Last »

Recent Posts

  • Genetic risk of ADHD may boost odds of Alzheimer’s in old age
  • Transcranial Direct Current Stimulation vs Sham for the Treatment of Inattention in Adults
  • Molecular Psychiatry: Astrocyte Biomarker Signatures of Amyloid-β and Tau Pathologies in Alzheimer’s Disease
  • Pitt Psychiatry Awarded $33.5M NIH Program Project Grant Focused on the Pathological and Clinical Progression of AD
  • Study Challenges Dogma Behind Alzheimer’s Disease Drug Trials

Website by